CN1309982A - Oral hemostatic traditional Chinese medicine - Google Patents
Oral hemostatic traditional Chinese medicine Download PDFInfo
- Publication number
- CN1309982A CN1309982A CN 00103088 CN00103088A CN1309982A CN 1309982 A CN1309982 A CN 1309982A CN 00103088 CN00103088 CN 00103088 CN 00103088 A CN00103088 A CN 00103088A CN 1309982 A CN1309982 A CN 1309982A
- Authority
- CN
- China
- Prior art keywords
- air bladder
- mentioned
- chinese medicine
- pseudosciaenae seu
- bladder pseudosciaenae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 35
- 230000002439 hemostatic effect Effects 0.000 title claims abstract description 10
- 239000009636 Huang Qi Substances 0.000 claims abstract description 7
- 241000252335 Acipenser Species 0.000 claims description 15
- 210000004712 air sac Anatomy 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 6
- 229920001353 Dextrin Polymers 0.000 claims description 4
- 239000004375 Dextrin Substances 0.000 claims description 4
- 235000019425 dextrin Nutrition 0.000 claims description 4
- 230000004520 agglutination Effects 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 235000015110 jellies Nutrition 0.000 claims description 3
- 239000008274 jelly Substances 0.000 claims description 3
- 208000032843 Hemorrhage Diseases 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 8
- 241000405414 Rehmannia Species 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 241001073507 Callicarpa Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 239000004833 fish glue Substances 0.000 abstract 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 1
- 230000035876 healing Effects 0.000 abstract 1
- 208000031169 hemorrhagic disease Diseases 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 206010027514 Metrorrhagia Diseases 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 229940079593 drug Drugs 0.000 description 7
- 230000023597 hemostasis Effects 0.000 description 5
- 206010013908 Dysfunctional uterine bleeding Diseases 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- HBGOLJKPSFNJSD-UHFFFAOYSA-N Etamsylate Chemical compound CC[NH2+]CC.OC1=CC=C(O)C(S([O-])(=O)=O)=C1 HBGOLJKPSFNJSD-UHFFFAOYSA-N 0.000 description 3
- 208000019255 Menstrual disease Diseases 0.000 description 3
- 229950006142 carbazochrome salicylate Drugs 0.000 description 3
- 229960004817 etamsylate Drugs 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- CELKBRMLNUNCIP-HTFHIHPASA-M sodium;2-hydroxybenzoate;[(e)-(3-hydroxy-1-methyl-6-oxo-2,3-dihydroindol-5-ylidene)amino]urea Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O.NC(=O)N\N=C/1C(=O)C=C2N(C)CC(O)C2=C\1 CELKBRMLNUNCIP-HTFHIHPASA-M 0.000 description 3
- 208000007502 anemia Diseases 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000003433 contraceptive agent Substances 0.000 description 2
- 230000002254 contraceptive effect Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000002513 anti-ovulatory effect Effects 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 201000009267 bronchiectasis Diseases 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 201000006828 endometrial hyperplasia Diseases 0.000 description 1
- 230000000025 haemostatic effect Effects 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 239000002874 hemostatic agent Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000027758 ovulation cycle Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
An oral hemostatic Chinese medicine is prepared from (by weight) radix astragali 24-36; 10-20 parts of angelica; 10-20 parts of prepared rhizome of rehmannia; 8-36 parts of fish glue; 6-12 parts of callicarpa; 6-12 of prepared licorice root, which is mainly used for treating serious intractable uterine functional hemorrhage and various hemorrhagic diseases with unobvious curative effect by using conventional hemostatic medicaments, is completely prepared from traditional Chinese medicines, has no toxic or side effect, remarkable curative effect and no relapse after healing.
Description
The present invention relates to a kind of hemorrhage, specifically is a kind of Orally taken hemostatic Chinese medicine.
In hemostatic agent, many kinds of preparations are arranged, for example etamsylate, vitamin K, carbazochrome salicylate, GONGXUENING etc., these medicaments are conventional therapy medication or auxiliary treatment medication, versatility is stronger, but drug effect is obvious inadequately.The course of treatment, longer curative effect was slower, when conditions of patients is light, can obtain therapeutic effect, when conditions of patients is serious, then be difficult for obtaining the effect of basic treatment, some has certain therapeutic effect by the synthetic Western medicine of chemical substance, but Western medicine often toxic and side effects is bigger, can stimulate stomach discomfort, and price is more expensive.
The purpose of this invention is to provide a kind of Orally taken hemostatic Chinese medicine, be mainly used in the serious obstinate dysfunctional uterine hemorrhage of treatment and be used for the treatment of various hemorrhages with conventional hemorrhage DeGrain, it is made by Chinese medicine fully, has no side effect.
The objective of the invention is to realize by following technical scheme.A kind of Orally taken hemostatic Chinese medicine is characterized in that it is made up of following compositions in weight percentage:
Radix Astragali 24-36 Radix Angelicae Sinensis 10-20 Radix Rehmanniae Preparata 10-20
Air Bladder pseudosciaenae seu Acipenser 8-36 Folium Callicarpae Formosanae 6-12 Radix Glycyrrhizae Preparata 6-12
It is made by following step preface:
(1) batching, by the prescription each component is prepared stand-by,
(2) will prepare burden in each component except that Air Bladder pseudosciaenae seu Acipenser be placed in the medicine pot cooked, filter and remove residue,
(3) Air Bladder pseudosciaenae seu Acipenser is cut in bulk, mixes, boiled 1-2 hour,, make medicinal liquid agglutination thing to the Air Bladder pseudosciaenae seu Acipenser dissolving with High Temperature High Pressure with well-done above-mentioned medicinal liquid,
(4) the straticulation thing is dried in the cooling of above-mentioned jelly, is cut into small pieces again, mix with Pulvis Talci antiseizedly, fry with slow fire then, make the beading thing,
(5) will be ground into smalls behind the above-mentioned pearl cool drying,
(6) with above-mentioned smalls be dried into preparation after dextrin mixes,
(7) said preparation is packed as goods.
The present invention is the hemostasis principal agent with the Air Bladder pseudosciaenae seu Acipenser, its function is that clearing away heat to stop bleeding, puckery leakage restrain, nourish blood, the main effect of removing heat from blood, nourishing muscle arteries and veins, the Folium Callicarpae Formosanae function is that hemostasis, removing heat from blood are as accessory drugs, with the Radix Astragali, Radix Angelicae Sinensis, Radix Rehmanniae Preparata carry out invigorating the spleen and replenishing QI, enrich blood, promoting the circulation of blood, treating blood disorders, the YIN nourishing tonify deficiency, moisturize and seek treatment, Radix Glycyrrhizae Preparata has benefiting QI and nourishing blood, and and the function of all medicines.Above-mentioned each Chinese medicinal components compatibility is formed, and with the major function that reaches hemostasis, enriches blood, its medicine is concentrated one's efforts by force, and therapeutic goal is single, particularly evident in efficacy to hemorrhages such as gynecological's metrorrhagia.
Do concrete introduction with embodiment below.
Embodiment 1 makes electuary.
One, prescription: take off row component (by weight percentage):
The Radix Astragali 30 Radix Angelicae Sinensis 15 Radix Rehmanniaes Preparata 15
Air Bladder pseudosciaenae seu Acipenser 20 Folium Callicarpae Formosanae 10 Radix Glycyrrhizae Preparatas 10
Two make:
(1) batching is chosen decontamination by above-mentioned prescription with each component, the difference ready for use,
(2) will prepare burden in 5 kinds of components except that Air Bladder pseudosciaenae seu Acipenser be placed in the pot and boil, change slow fire and boiled 1.5 hours, filter and remove medicinal residues,
(3) Air Bladder pseudosciaenae seu Acipenser being cut into fritter, mix with above-mentioned filtered medicine liquid, is 0.15 to 0.2MPa at pressure, boils 1.5 hours under 150 ℃, is dissolved in the medicinal liquid to Air Bladder pseudosciaenae seu Acipenser, makes medicinal liquid agglutination thing,
(4) straticulation is dried in the cooling of above-mentioned jelly, be cut into small pieces again, mix with Pulvis Talci antiseizedly, fry with slow fire then, to the beading thing,
(5) with behind the above-mentioned pearl cool drying, be ground into smalls,
(6) with above-mentioned smalls with after dextrin mixes by weight at 1: 1, oven dry is pulverized and is made electuary,
(7) be finished product with the said preparation bag distribution packaging.
Embodiment 2 makes pill
One, prescription: take off row component (by weight percentage):
The Radix Astragali 32 Radix Angelicae Sinensis 20 Radix Rehmanniaes Preparata 20
Air Bladder pseudosciaenae seu Acipenser 8 Folium Callicarpae Formosanae 10 Radix Glycyrrhizae Preparatas 10 2 are made:
Its make step preface remove (6) and embodiment 1 different, it is all identical that all the other go on foot prefaces, goes on foot preface (6) for above-mentioned smalls and dextrin mixing and water adding are made ball, is dried to pill.
In sum, Hemostatic of traditional herb medicine of the present invention, with the Air Bladder pseudosciaenae seu Acipenser is the hemostasis principal agent, with the Radix Astragali, Folium Callicarpae Formosanae, Radix Angelicae Sinensis, Radix Rehmanniae Preparata is auxilliary, with Radix Glycyrrhizae Preparata coordinating the actions of various ingredients in a prescription component, above-mentioned each tcm components material compatibility is formed, its therapeutic purposes are single, medicine is concentrated one's efforts by force, is used for the treatment of hemorrhage, is particularly suitable for treating symptoms such as women's metrorrhagia.
Introduce the clinical practice situation below.This medicament once used under unexposed prescription situation clinically, treat all kinds of women's anovulatory dysfunctional uterine hemorrhages altogether and claim metrorrhagia again, totally 30 examples, main drugs compared is GONGXUENING, carbazochrome salicylate, etamsylate, contraceptive, norlutin, under the ineffective situation of above-mentioned drugs compared, take this preparation, 100% is effective as a result, and gross hemostasis rate reaches 98%.Be illustrated with following model case:
Case 1, poplar * * woman 41 years old, the readme menoxenia, amount is many, and 3 years, first visit on February 6 in 98 year.The patient after in utero putting ring in 94 years, excessive menstruation, menoxenia behind the decyclization, measure still many, menstrual cycle 10-23 days, the amount clot is arranged more, once failed to respond to any medical treatment with GONGXUENING, carbazochrome salicylate, contraceptive.January 2, the amount of rising multirow was clean substantially on 12nd through 10 days, and current menstruation is many 4-5 of the amount of rising sky on February 1, and big clot is arranged, and is nervous with dizziness, malaise.Check RBC3.36 * 10
12/ l, HGB96g/l.Clinical principium diagnosis, doctor trained in Western medicine: 1, dysfunctional uterine hemorrhage, 2, secondary anemia, the traditional Chinese medical science: metrorrhagia.Obtain the patient and agree, give medicine Zhixue soluble granules of the present invention, each 1 bag, every day 2 times.
Further consultation on February 9.Patient's readme take medicine the back metrorrhagia obviously reduce, take medicine 3 days hemorrhage clean substantially.
March 6 returned and examines, and readme menstruation on March 1 is risen on schedule, measures more preceding obvious minimizing, and a couple of days of passing through is clean, not recurrence again.
Case 2, open * * woman 43 years old, surplus the readme menoxenia 3 years, metrorrhagia 50 day.First visit on January 24 in 98 year.
Patient's imbalance in the period, 3 is irregular, amenorrhea sometimes, and metrorrhagia is unclean sometimes, and is few for a long time during amount, does diagnostic and measures, and pathological replacement was taken medicines such as etamsylate, norlutin, poor effect for " endometrial hyperplasia is long ".It is unclean so far surplus the December 3 days, metrorrhagia 50, and the companion is dizzy, malaise, symptoms such as insomnia.
Check: RBC3.67 * 10
12/ l, HGB7.4g/l clinical impression, doctor trained in Western medicine: 1, dysfunctional uterine hemorrhage, 2, secondary anemia.The traditional Chinese medical science: metrorrhagia.
Obtain the patient and agree, give Chinese medicine Zhixue soluble granules of the present invention, every day 2 times, each 1 bag.
Further consultation on January 27.Took above-mentioned medicine 4 days, blood volume obviously reduces, and the menses complexion changed is shallow, looks into visible a little the courageous and upright secretions of packing paper.
After 2 days, blood is clean through clothes hemorrhage Zhixue soluble granules of the present invention.
Use diseases such as this medicament was once hemorrhage to pulmonary carcinoma, bronchiectasis is hemorrhage in addition and be applied to clinical treatment, good haemostatic effect is also arranged, during existing further research is used.
Claims (2)
1, a kind of Orally taken hemostatic Chinese medicine, it is characterized in that: it is made up of following compositions in weight percentage:
Radix Astragali 24-36 Radix Angelicae Sinensis 10-20 Radix Rehmanniae Preparata 10-20
Air Bladder pseudosciaenae seu Acipenser 8-36 Folium Callicarpae Formosanae 6-12 Radix Glycyrrhizae Preparata 6-12
2, Orally taken hemostatic Chinese medicine according to claim 1 is characterized in that, it is made by following step preface:
(1) batching, by the prescription each component is prepared stand-by,
(2) will prepare burden in each component except that Air Bladder pseudosciaenae seu Acipenser be placed in the medicine pot cooked, filter and remove residue,
(3) Air Bladder pseudosciaenae seu Acipenser is cut in bulk, mixes, boiled 1-2 hour,, make medicinal liquid agglutination thing to the Air Bladder pseudosciaenae seu Acipenser dissolving with High Temperature High Pressure with well-done above-mentioned medicinal liquid,
(4) the straticulation thing is dried in the cooling of above-mentioned jelly, is cut into small pieces again, mix with Pulvis Talci antiseizedly, fry with slow fire then, make the beading thing,
(5) will be ground into smalls behind the above-mentioned pearl cool drying,
(6) with above-mentioned smalls be dried into preparation after dextrin mixes,
(7) said preparation is packed as goods.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00103088 CN1309982A (en) | 2000-02-24 | 2000-02-24 | Oral hemostatic traditional Chinese medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00103088 CN1309982A (en) | 2000-02-24 | 2000-02-24 | Oral hemostatic traditional Chinese medicine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1309982A true CN1309982A (en) | 2001-08-29 |
Family
ID=4576758
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 00103088 Pending CN1309982A (en) | 2000-02-24 | 2000-02-24 | Oral hemostatic traditional Chinese medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1309982A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005077202A1 (en) * | 2004-01-21 | 2005-08-25 | Yutian Group | Fish maw glue products and preparation process thereof |
| CN107397208A (en) * | 2016-07-20 | 2017-11-28 | 吴登成 | Using fish glue as functional food of principal component and application thereof |
-
2000
- 2000-02-24 CN CN 00103088 patent/CN1309982A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005077202A1 (en) * | 2004-01-21 | 2005-08-25 | Yutian Group | Fish maw glue products and preparation process thereof |
| CN107397208A (en) * | 2016-07-20 | 2017-11-28 | 吴登成 | Using fish glue as functional food of principal component and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LT5433B (en) | Pharmaceutical composition for the treatment of cardiovascular and cerebrovascular diseases | |
| CN100506247C (en) | A traditional Chinese medicine composition for oral administration of functional uterine bleeding | |
| CN104958607A (en) | Traditional Chinese medicine composition for treating burning mouth syndromes of climacteric women and preparation method thereof | |
| CN101229322A (en) | External medicine for treating surgery and dermatology department diseases and preparing method thereof | |
| CN102688472B (en) | Medicinal composition for preventing or relieving yang deficiency syndrome of tumor patient | |
| CN102078527A (en) | Traditional Chinese medicine formula for treating urinary calculus | |
| CN101028325B (en) | Medicinal composition containing sailonggu, and its preparation and quality detection method | |
| CN112426461A (en) | Traditional Chinese medicine composition for treating gouty arthritis and preparation method and application thereof | |
| CN109453288B (en) | Pharmaceutical composition and traditional Chinese medicine raw material composition for treating plasma cell mastitis | |
| CN103638199B (en) | A kind ofly prevent and treat Chinese medicine composition of neurasthenia and senile dementia and preparation method thereof | |
| CN103655735B (en) | One treats beriberi, the agent of skin pruritus foam washing | |
| CN102657795A (en) | Traditional Chinese medicine preparation for promoting postoperative incision healing | |
| CN104826029A (en) | Traditional Chinese medicine composition for treating breast cancer and application of traditional Chinese medicine composition | |
| CN102343019B (en) | Chinese medicinal composition for treating amenorrhea and preparation method of preparation thereof | |
| CN1309982A (en) | Oral hemostatic traditional Chinese medicine | |
| CN101890081A (en) | Formula of Chinese medicament for treating female infertility and processing method of Chinese medicament | |
| CN111558008A (en) | A kind of weight loss and fat-reducing belly button patch, preparation method and application | |
| CN1759871A (en) | A kind of hemostatic capsule and its preparation process | |
| CN114515321B (en) | Yang-warming and uterus-warming ointment formula and application thereof | |
| CN1102044C (en) | Draco nis sanguis micro sponge agent and its preparing technology | |
| CN101066385A (en) | Chinese medicine for treating metrorrhagia | |
| CN101991838A (en) | Medicinal composition for curing osteoproliferation, rheumatism, rheumatoid diseases and herniated disk | |
| CN1895644A (en) | Medicine for shortening lying-in time and treating artificial abortion sequela | |
| CN1059111C (en) | Capsule of American ginseng and astragalus membranaceus | |
| CN106361984A (en) | Nine-raw-material blood stanching powder and preparing method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| AD01 | Patent right deemed abandoned | ||
| C20 | Patent right or utility model deemed to be abandoned or is abandoned | ||
| AD01 | Patent right deemed abandoned | ||
| C20 | Patent right or utility model deemed to be abandoned or is abandoned |